15 Other income/expenses

15 Other income/expenses

Total other income/expenses amounted to an expense of € 1 million (2018: income of € 24 million) and is comprised of the following items:

  • Gain on disposal: € 41 million in 2019 and is related to the divestment of Niferex® (iron supplement) franchise in China (€ 47 million in 2018 related to the sale of Innere Medizin and non-core Established Brand products)
  • Other expenses: € 42 million in 2019, relate mainly to Distilbène provision and intellectual property fees (2018: € 59 million and mainly relate to intellectual property fees and Distilbène provision)
  • In 2018 other income of € 36 was recognized related to the recognition of the cumulative amount of exchange differences for legal entities liquidated in 2018. These exchange differences were previously carried forward in other comprehensive income.